Business
Mayne chases larger slice of US contraception market with China deal – Sydney Morning Herald
Mayne Pharma has found a new Chinese supplier to roll out new pill brands in the US.
“Each product market has about six to eight generic competitors, but we are hoping to grab that additional margin
Continue Reading
-
Business23 hours agoThis ASX dividend stock could be primed for a rebound
-
Noosa News23 hours agoDouble-digit rainfall raises farmers’ hopes of bumper harvest in southern WA
-
General23 hours agoUnions call for stricter AI restrictions in workplaces
-
Noosa News24 hours agoJCU hosts second Pride event – Proctor